Scenic Biotech taps Dr. Bürli as Chief Scientific Officer to lead development of innovative drug candidate pipeline fueled by the company’s ...

Bürli will lead the development and advance the pipeline of modifier therapies in neuro- and metabolic diseases.

Modifiers (usually 2-digits) are added to the main procedure code to signify that the procedure has been altered by a distinct factor. Modifiers are accepted by most payors. Modifiers can increase or ...